Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on May 23, 2025

Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2

Immix Biopharma Further Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2

– Patient enrollment exceeding expectations – – 14 U.S. sites actively enrolling; 10 U.S. sites added since last update – – Anticipate completing NEXICART-2 clinical trial ahead of schedule – LOS ANGELES, CA, May 23, 2025 (GLOBE NEWSWIRE) -- Immix …

Etrion Releases First Quarter 2025 Results and Additional Return of Capital

Etrion Releases First Quarter 2025 Results and Additional Return of Capital

GENEVA, May 23, 2025 (GLOBE NEWSWIRE) -- Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and …

Wix Acquires Hour One to Expand Generative AI Capabilities and Accelerate Product Innovation

Wix Acquires Hour One to Expand Generative AI Capabilities and Accelerate Product Innovation

NEW YORK-- Today Wix.com Ltd. (Nasdaq: WIX), the leading SaaS website builder platform globally1, announced its acquisition of Hour One, a pioneer in generative AI media creation. This acquisition marks yet another milestone in Wix’s transformation into a …

Forte Minerals Announces Private Placement of up to C$2.4 Million

Forte Minerals Announces Private Placement of up to C$2.4 Million

“Not for distribution to United States newswire services or for dissemination in the United States.” VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA), …

TerraVest Industries Inc. Announces Closing of Upsized Bought Deal Offering of Common Shares and Concurrent Closing of the Over-Allotment Option

TerraVest Industries Inc. Announces Closing of Upsized Bought Deal Offering of Common Shares and Concurrent Closing of the Over-Allotment Option

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- TerraVest Industries Inc. (TSX:TVK) (“TerraVest” or the “Company”) is pleased to announce that it has closed its previously …

ALRMiner Launches Smarter System to Boost Returns and Cut Energy Use

ALRMiner Launches Smarter System to Boost Returns and Cut Energy Use

Monmouth, Monmouthshire, May 23, 2025 (GLOBE NEWSWIRE) -- The platform has evolved to accommodate the needs of its growing customer base throughout the years. ALRMiner introduced their revolutionary Mining Optimization System to enhance operational …

Clip Money Inc. Reports First Quarter 2025 Results

Clip Money Inc. Reports First Quarter 2025 Results

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the …

Tilray Medical bringt die bekannte kanadische Cannabismarke Good Supply nach Deutschland

Tilray Medical bringt die bekannte kanadische Cannabismarke Good Supply nach Deutschland

NEUMÜNSTER, Deutschland, May 23, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führendes Unternehmen im Bereich des medizinischen Cannabis, das die …

Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne

Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne

NEUMÜNSTER, Allemagne, 23 mai 2025 (GLOBE NEWSWIRE) -- Tilray Medical (« Tilray »), une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de …

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity Opinion follows FDA approval and MHRA conditional marketing …

Elko County’s Latest Virtual Tax Sale on Bid4Assets Results in Nearly 200 Properties Sold

Elko County’s Latest Virtual Tax Sale on Bid4Assets Results in Nearly 200 Properties Sold

ELKO, Nev., May 23, 2025 (GLOBE NEWSWIRE) -- The Elko County, NV Treasurer-Tax Collector’s office conducted the county’s latest virtual tax foreclosure sale with Bid4Assets, a leading online auction marketplace for distressed real estate sales. The sale, …

Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting

Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting

Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a First-in-Class In Situ Personalized Immunotherapy Platform  Abstract published on podium presentation that will take place during the “Developmental …

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer

IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer

Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group Women treated with IMNN-001 and standard of care chemotherapy plus PARP …

FRO - Q1 2025 Presentation

FRO - Q1 2025 Presentation

Please find enclosed the presentation of Frontline plc´s first quarter 2025 results to be held on the webcast / conference call 23 May, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 – 12 of the …

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

COPENHAGEN, Denmark, May 23, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its first quarter 2025 financial results on …

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for both adults and children with NF1-PN – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, …

ScribeCanada to Showcase Care Team Support Solutions at Two Leading Healthcare Conferences this Spring

ScribeCanada to Showcase Care Team Support Solutions at Two Leading Healthcare Conferences this Spring

VANCOUVER, B.C., May 23, 2025 (GLOBE NEWSWIRE) -- ScribeCanada, a care team support solutions provider, is excited to announce its participation in two leading healthcare conferences this spring. From May 23-28, ScribeCanada will attend the International …

As Bitcoin Price Soars to $110,000, XRP and Dogecoin Whale Investors Turn to XY Miners Cloud Mining

As Bitcoin Price Soars to $110,000, XRP and Dogecoin Whale Investors Turn to XY Miners Cloud Mining

Los Angeles, CA, May 23, 2025 (GLOBE NEWSWIRE) -- As Bitcoin price skyrockets past $110,000 in 2025, a new wave of crypto momentum is sweeping across the market. Whale investors in XRP and Dogecoin are shifting their strategies, turning away from …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service